Stories are generated from ORTEX data and reviewed by the ORTEX team. How we publish
RPC heads into November earnings with a crowded ownership register, a stock trading well below analyst targets, and a short base that has quietly rebuilt over the past month.
The most notable feature of the ownership picture is the activist presence. Robert Alpert carries a Schedule 13D filing on the stock, the highest-signal disclosure in the SEC register, meaning his position was established with an intent to influence the company. His latest filing showed a stake of 4.9%, trimmed from 5.3%, and because he has now slipped below the 5% threshold he is under no obligation to file again if he exits further. That ambiguity is worth watching. Alongside the 13D, a cluster of new passive filers has appeared in 2026: RJDT Holdings disclosed an 11.58% stake in July, and CAZ Investments filed a 5.8% Schedule 13G in March. Together the top five holders account for more than 37% of shares outstanding, making this an unusually concentrated register for a company of this size.
The Street still sees meaningful value here, though recent analyst moves have been one-directional. Both Oppenheimer and Barclays trimmed their price targets following the August earnings release, Oppenheimer cutting to $15 from $16 while maintaining Outperform, Barclays dropping to $11 from $12 while keeping Overweight. The mean target of $12.75 implies roughly 61% upside to the current $7.91 close. That gap is too wide to ignore, but it also reflects how far the stock has fallen: down nearly 7% over the past month and still nursing a significant year-to-date loss. Valuation multiples are modest. The P/E sits at 7.0x, the EV/EBITDA at 8.3x, both drifting lower over the past 30 days. The dividend factor score ranks in the 91st percentile, suggesting the yield is one of the stronger arguments in the bull case.
Positioning in the lending market is relaxed rather than charged. Short interest at 4.8% of the free float is not extreme, but it has grown about 2.7% over the past month, recovering ground lost in mid-September when the count briefly dropped sharply. Borrow availability is ample at 274%, meaning there are nearly three shares available to lend for every share already borrowed. The cost to borrow at 0.57% is low, though it has risen 29% over the past month. Earlier this year, in late August, borrowing costs briefly spiked above 5% before collapsing back quickly, an episode that suggests episodic demand from short sellers but no sustained squeeze dynamic. Options positioning is firmly call-heavy: the put/call ratio of 0.19 is barely above its 20-day average and sits well below the 52-week high of 2.09, meaning there is little appetite for downside protection among options traders.
The ORTEX short score of 58.6 has edged lower over the past week from a recent peak above 59.9, nudging down the combined score fractionally. The short score percentile rank of 12 suggests shorts are not heavily crowded relative to the broader universe, consistent with the availability and cost-to-borrow picture. Recent insider filings are largely uninformative: the only open-market activity in the past 90 days was a tax-withholding transaction (code F) at $7.91, a compensation mechanic rather than a conviction signal. The net share count over 90 days is flat.
RPC reports Q3 results on November 6. The last two prints each produced negative one-day and five-day reactions, with the stock falling roughly 2 to 3% on the day and extending those losses modestly across the week after. With the stock sitting at a large discount to consensus targets but short interest continuing its slow rebuild, the November print will be the next test of whether the wide analyst-to-price gap starts to close or widen further.
See the live data behind this article on ORTEX.
Open RPC on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.